Screening for Heart Failure Using a Multimodal Wearable Device

Last updated: October 1, 2025
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Overall Status: Completed

Phase

N/A

Condition

Heart Failure

Hyponatremia

Congestive Heart Failure

Treatment

Watch HOP

Clinical Study ID

NCT06335264
2024-9987
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to find out if there are any patterns in the way people's bodies react to physical activities and their voices when they have heart failure, a disease where the heart cannot function sufficiently. To do this, the investigators will use a smartwatch that can measure multiple signals like the participant's heart rate and movement. Investigators will ask participants with and without heart failure to wear the Watch HOP (from HOP-Child Technologies Inc.) and sensors during physical tasks at their clinic visit at the McGill University Health Centre. Researchers will also record the participants' voices between their visits. The key signals can help find who is at risk for heart failure or develop new ways to monitor and treat it.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Able to follow up with the study protocol schedule

  2. Life expectancy > 1 year

  3. Case group only

  4. Clinical signs and/or symptoms of heart failure caused by a structural and/orfunctional cardiac abnormality, as defined by Bozkurt et al. [2021], diagnosedat the cardiovascular clinic

  5. NT-proBNP levels > 125 pg/L or objective evidence of cardiogenic pulmonary orsystemic congestion

  6. One of the following; i. For HFpEF, LVEF ≥ 50% ii. For HFmrEF, LVEF 41-49% iii. For HFrEF, LVEF ≤ 40%

  7. Control group only

  8. Absence of known clinical heart failure history.

  9. Absence of criteria above in the case group.

Exclusion

Exclusion Criteria:

  1. Any person who does not meet the above criteria or who refuses to participate

  2. Undergoing chemotherapy or dialysis

  3. In addition, the following list of criteria are specific to accurate wrist wearablemeasurements:

  4. Skin burns or rashes on the measurement locations (wrist for wearable, fingerfor oximeter, chest for Polar ECG)

  5. Patients with tremors

  6. Recent use of dermatological creams, ointments, or lotions at the recordingarea

Study Design

Total Participants: 56
Treatment Group(s): 1
Primary Treatment: Watch HOP
Phase:
Study Start date:
January 15, 2024
Estimated Completion Date:
August 31, 2025

Study Description

Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by significant morbidity and mortality, poor functional capacity and quality of life, and high costs. Logistic and economic difficulties prove screening for HF challenging for some populations, such as people with reduced mobility and the elderly. Sensor technologies and data processing algorithms, including artificial intelligence, represent an opportunity to systematically identify patients suffering from HF as a complementary tool for echocardiography. The ability to compute digital biomarkers using complex models from wearable data requires identifying the key parameters that are associated with the presence of HF. A multisensorial wearable device can be utilized to develop digital biomarkers for population-based screening of HF. The present study aims to evaluate the best signals from a wearable device to identify digital signals (aka digital biomarkers) that are most associated with HF, including all ejection fraction types.

For this study, investigators will recruit 27 participants with HF and 27 without HF. The primary objective of this study is to analyze the key physiological parameters recorded from the platform devices that can develop a digital biomarker for the presence of prevalent HF.

Connect with a study center

  • McGill University Health Centre

    Montreal, Quebec H4A 3J1
    Canada

    Site Not Available

  • McGill University Health Centre

    Montreal 6077243, Quebec 6115047 H4A 3J1
    Canada

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.